Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
This is a Phase Ib/IIb, randomized, two-cohort, open-label, multicenter study of intravesical N-803 plus BCG versus BCG alone, in BCG naïve patients with high-grade NMIBC.
Sponsor: ImmunityBio, Inc.
Check if you qualify for this bladder cancer clinical trial in Los Angeles, CA
If you're searching for bladder cancer treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.